Using basic biochemistry, animal models, and human subjects, the Washington Lab works to unravel novel mechanisms by which platelets' interaction with the immune system direct disease outcomes. The lab studies a platelet receptor TLT-1 (the Triggering Receptor Expressed in Myeloid cells (TREM) Like Transcript -1) that appears to function at the interface of hemostasis and inflammation directed by the immune system.